abstract |
The present invention relates to a compound of formula (I): N) N'N N , (I). The compound has apoptosis signal-regulating kinase ("ASKl") inhibitory activity, and is thus useful in the treatment of diseases such as kidney disease, diabetic nephropathy and kidney fibrosis. |